Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Dr. Anissa Boumlic-Courtade is the Associate Director for the vaccine initiative in EMEA with Process Solutions division of Merck Life Sciences. Dr. Boumlic-Courtade joined Merck in 2009 and has held various positions focused on downstream processing, virus safety, and monoclonal antibody and vaccine manufacturing. Dr. Anissa Boumlic-Courtade holds a M. Sc. in Biotechnology Engineering from the Ecole Supérieure de Biotechnologie (ESBS) de Strasbourg (France) as well as a Ph.D. in Molecular Biology and Biochemistry from the University of Strasbourg co-directed with the University of Thessaly (Greece).
Preventable diseases vaccines save millions of lives but are not always delivered when needed to a large fraction of the population. In addition, there are a number of infectious diseases that still remain without cure or vaccine. Innovations in process development and manufacturing are unavoidable to enable release of existing and novel vaccines and their delivery where and when they are mostly needed. This presentation will outline where innovative approaches and technologies while developing and/or optimizing the process and at manufacturing scale can accelerate clinical phases and compress the time to market of highly needed vaccines. Furthermore, using case studies like Ebola and influenza outbreaks, challenges will also be highlighted in pandemic situations and approaches will be discussed on how to alleviate roadblocks and be better prepared to manufacture vaccines in urgent situations.